Brain atrophy: hippocampal asymmetry


Quibim’s Hippocampal atrophy & asymmetry quantifies the volumes of the right and left hippocampus to help assess hippocampal atrophy (HA) and asymmetry early. The suite may be used to aid diagnosis and monitoring of patients by characterizing subtle alterations in hippocampal physiology and morphology that are associated with temporal lobe epilepsy (TLE).
Product specifications Information source: Vendor
Last updated: Feb. 11, 2022
Product name Brain atrophy: hippocampal asymmetry
Company Quibim
Subspeciality Neuro
Modality MR
Disease targeted Temporal lobe epilepsy (TLE)
Key-features Main region volume and total volume
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Patients associated with Temporal lobe epilepsy (TLE)
Input MRI T1 GRE 3D T1 Fast Gradient Echo
Input format
Output One-page structured report: 3D hippocampus render, hippocampus segmentation, table with volume statistics, normative graphs of volume and asymmetry
Output format DICOM Secondary Capture / PDF
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time > 10 minutes
Certified, Class IIa , MDD
No or not yet
Market presence
On market since 01-2019
Distribution channels Alma HEALTH PLATFORM
Countries present (clinical, non-research use) 6
Paying clinical customers (institutes) 5+
Research/test users (institutes)
Pricing model License
Based on Number of installations, Number of analyses
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers